Stryker Net Acquisitions/Divestitures 2010-2025 | SYK

Stryker annual/quarterly net acquisitions/divestitures history and growth rate from 2010 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
  • Stryker net acquisitions/divestitures for the quarter ending March 31, 2025 were $-4.749B, a 1830.49% increase year-over-year.
  • Stryker net acquisitions/divestitures for the twelve months ending March 31, 2025 were $-8.309B, a 486.79% increase year-over-year.
  • Stryker annual net acquisitions/divestitures for 2024 were $-1.628B, a 317.44% increase from 2023.
  • Stryker annual net acquisitions/divestitures for 2023 were $-0.39B, a 84.78% decline from 2022.
  • Stryker annual net acquisitions/divestitures for 2022 were $-2.563B, a 656.05% increase from 2021.
Stryker Annual Net Acquisitions/Divestitures
(Millions of US $)
2024 $-1,628
2023 $-390
2022 $-2,563
2021 $-339
2020 $-4,222
2019 $-802
2018 $-2,451
2017 $-831
2016 $-4,332
2015 $-153
2014 $-916
2013 $-2,320
2012 $-154
2011 $-2,066
2010 $-265
2009 $-570
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $145.939B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.137B 27.79
Boston Scientific (BSX) United States $154.602B 38.70
EssilorLuxottica (ESLOY) France $128.884B 0.00
Medtronic (MDT) Ireland $105.694B 14.98
Haleon (HLN) United Kingdom $51.038B 29.05
Lonza Group Ag (LZAGY) Switzerland $49.182B 0.00
ResMed (RMD) United States $35.941B 27.00
GE HealthCare Technologies (GEHC) United States $32.753B 15.55
Agilent Technologies (A) United States $32.296B 20.98
Terumo (TRUMY) Japan $27.790B 36.10
Insulet (PODD) United States $22.791B 89.46
Koninklijke Philips (PHG) Netherlands $21.581B 15.51
Zimmer Biomet Holdings (ZBH) United States $18.467B 11.86
Baxter (BAX) United States $15.754B 11.76
Smith & Nephew SNATS (SNN) United Kingdom $12.622B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.194B 21.55
Lantheus Holdings (LNTH) United States $5.225B 13.18
Prestige Consumer Healthcare (PBH) United States $4.175B 18.65
Perrigo (PRGO) Ireland $3.730B 9.45
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.309B 24.40
Haemonetics (HAE) United States $3.259B 14.85
Envista Holdings (NVST) United States $3.129B 26.00
GN Store Nord (GNNDY) Denmark $2.215B 18.35
QuidelOrtho (QDEL) United States $2.080B 14.30
LeMaitre Vascular (LMAT) United States $1.832B 40.94
AtriCure (ATRC) United States $1.687B 0.00
Neogen (NEOG) United States $1.348B 17.25
Acuren (TIC) United States $1.300B 0.00
AdaptHealth (AHCO) United States $1.212B 12.30
Kestra Medical Technologies (KMTS) United States $1.165B 0.00
Green Thumb Industries (GTBIF) United States $1.111B 25.00
BioLife Solutions (BLFS) United States $1.060B 0.00
Phibro Animal Health (PAHC) United States $1.000B 12.78
InMode (INMD) Israel $0.922B 9.29
CeriBell (CBLL) United States $0.615B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.604B 0.00
Evolus (EOLS) United States $0.602B 0.00
Curaleaf Holdings (CURLF) Canada $0.582B 0.00
Valneva SE (VALN) France $0.535B 0.00
Owens & Minor (OMI) United States $0.502B 4.17
Tilray Brands (TLRY) Canada $0.468B 0.00
Capricor Therapeutics (CAPR) United States $0.461B 0.00
Surmodics (SRDX) United States $0.422B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.342B 0.00
Cresco Labs (CRLBF) United States $0.333B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.94
Canopy Growth (CGC) Canada $0.314B 0.00
Aurora Cannabis (ACB) Canada $0.310B 55.20
Sanara MedTech (SMTI) United States $0.261B 0.00
Viemed Healthcare (VMD) United States $0.260B 21.90
ZimVie (ZIMV) United States $0.250B 11.35
Sanuwave Health (SNWV) United States $0.241B 0.00
Verano Holdings (VRNOF) United States $0.237B 0.00
Cerus (CERS) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.207B 0.00
Quanterix (QTRX) United States $0.203B 0.00
Brainsway (BWAY) Israel $0.197B 52.15
Biote (BTMD) United States $0.197B 5.53
Omeros (OMER) United States $0.195B 0.00
Organigram Global (OGI) Canada $0.185B 0.00
High Tide (HITI) Canada $0.177B 0.00
Utah Medical Products (UTMD) United States $0.177B 14.44
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.142B 17.46
Jin Medical (ZJYL) China $0.119B 0.00
TerrAscend (TSNDF) Canada $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.089B 11.52
MacroGenics (MGNX) United States $0.088B 0.00
Agape ATP (ATPC) $0.088B 0.00
Quipt Home Medical (QIPT) United States $0.077B 0.00
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.072B 0.00
Apyx Medical (APYX) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
United Health Products (UEEC) United States $0.054B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Modular Medical (MODD) United States $0.048B 0.00
United-Guardian (UG) United States $0.038B 13.19
Rockwell Medical (RMTI) United States $0.032B 0.00
Nephros (NEPH) United States $0.028B 37.57
Safety Shot (SHOT) United States $0.021B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00